Deus RapidScreen Becomes First CAD To Gain FDA Approval For Lung Cancer
This article was originally published in The Gray Sheet
Executive Summary
The integration of Deus Technologies' RapidScreen RS-2000 computer-aided diagnosis (CAD) software for lung cancer into Marconi Medical Systems' imaging devices could be facilitated by a recent U.S. distribution agreement between the companies.